Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -69,685 | -51,418 | -29,362 | -59,248 | -47,762 |
| Depreciation Amortization | -344 | -239 | 127 | 130 | 154 |
| Other Working Capital | -377 | 5,371 | 1,288 | 2,460 | -1,241 |
| Other Operating Activity | 3,970 | 4,189 | 2,134 | 6,942 | 3,593 |
| Operating Cash Flow | $-66,436 | $-42,097 | $-25,813 | $-49,716 | $-45,257 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -726 | -12,957 | N/A | N/A | N/A |
| PPE Investments | -151 | -191 | -61 | -212 | -200 |
| Net Acquisitions | N/A | N/A | N/A | -528 | N/A |
| Investing Cash Flow | $-877 | $-13,148 | $-61 | $-740 | $-200 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,020 | N/A | N/A | N/A | N/A |
| Debt Repayment | -925 | N/A | -985 | -1,034 | -3 |
| Common Stock Issued | 30,876 | 3,210 | 35,934 | -7 | 10,487 |
| Other Financing Activity | 0 | 0 | 93,453 | 0 | 0 |
| Financing Cash Flow | $30,971 | $3,210 | $128,402 | $-1,041 | $10,484 |
| Beginning Cash Position | 67,131 | 119,166 | 16,638 | 68,135 | 103,108 |
| End Cash Position | 30,789 | 67,131 | 119,166 | 16,638 | 68,135 |
| Net Cash Flow | $-36,342 | $-52,035 | $102,528 | $-51,497 | $-34,973 |
| Free Cash Flow | |||||
| Operating Cash Flow | -66,436 | -42,097 | -25,813 | -49,716 | -45,257 |
| Capital Expenditure | -151 | -191 | -61 | -212 | -200 |
| Free Cash Flow | -66,587 | -42,288 | -25,874 | -49,928 | -45,457 |